FNDC3A

FNDC3A is an endoplasmic reticulum transmembrane protein that functions both as a membrane anchor for cytoplasmic effector enzymes and as a tissue-level mediator of cell adhesion and extracellular matrix organization (PMID:16904100, PMID:32963011, PMID:32966780). Its best-defined molecular role is to recruit the TENT5/FAM46 family of non-canonical poly(A) polymerases—notably FAM46C/TENT5C—to the cytoplasmic face of the ER, where the FNDC3A/FAM46C complex stabilizes ER-targeted mRNAs and shapes the secretory output of the cell, increasing lysosome exocytosis, impairing autophagy, and driving accumulation of intracellular protein aggregates and apoptosis in multiple myeloma cells (PMID:32963011, PMID:32966780). Binding is mediated by a member-specific C-terminal region of TENT5C that is necessary and sufficient for FNDC3 association and ER localization; multiple myeloma mutations in this region disrupt FNDC3 binding or TENT5C stability and abrogate its tumor-suppressive, immunoglobulin-promoting activity (PMID:42247288). This circuit is gated by the autophagic receptor p62, whose ZZ domain sequesters FAM46C in aggregates and prevents its productive engagement with FNDC3A (PMID:32966780, PMID:32963011). Beyond this complex, FNDC3A is genetically required for spermatid–Sertoli cell adhesion in the testis, where its loss causes male sterility (PMID:16904100), and it regulates extracellular matrix and epidermal organization during zebrafish fin development and regeneration (PMID:31527654). FNDC3A loss in triple-negative breast cancer cells suppresses EMT, invasion, and stemness with concomitant inhibition of the YAP1 transcriptional program (PMID:40120859), and recombinant FNDC3A acts extracellularly on bovine granulosa cells to dampen IGF1-dependent progesterone and lactate secretion (PMID:38513348).

1. 2006 High

   Established the first in vivo function of FNDC3A by showing it is genetically required for a specific cell–cell adhesion event, defining the protein as essential for male fertility rather than merely expressed in testis.

   Evidence Loss-of-function deletion mapping and genetic complementation with a specific Fndc3a allele in sys mice, with immunohistochemistry

   PMID:16904100

   Open questions at the time

   • Molecular mechanism of adhesion not defined
   • No identified binding partner mediating spermatid–Sertoli attachment
   • Subcellular site of action versus membrane topology not resolved functionally
2. 2006 Medium

   Localized FNDC3A to acrosomal and cytoplasmic vesicular structures and noted a tail-anchor-like hydrophobic C-terminus, providing the first structural clue that the protein is membrane-associated.

   Evidence Immunohistochemical staining of staged mouse testis sections

   PMID:16904100

   Open questions at the time

   • ER membrane insertion inferred from sequence, not demonstrated
   • Localization not tied to function by domain rescue
3. 2008 Low

   Extended FNDC3A expression to a secretory cell type by localizing it to Golgi vesicles in odontoblasts, hinting at a role in matrix biosynthesis.

   Evidence Immunohistochemistry and subcellular localization in human odontoblasts

   PMID:18218838

   Open questions at the time

   • Single lab, single method (IHC) with no functional follow-up
   • Golgi versus ER localization not reconciled with later ER residency data
   • No demonstrated link to collagen or glycosaminoglycan synthesis
4. 2018 Medium

   Connected an FNDC3 ortholog to chaperonin function by showing a physical and genetic interaction with the TRiC/CCT subunit CCT3 governing neuronal morphogenesis.

   Evidence Co-IP/pulldown, genetic epistasis with double mutants, and neuronal rescue of Drosophila mtgo phenotypes

   PMID:30539716

   Open questions at the time

   • Demonstrated in Drosophila ortholog only
   • Relationship between CCT3 interaction and the mammalian ER/FAM46C role unknown
   • Direct binding interface not mapped
5. 2019 Medium

   Defined a developmental ECM function by showing FNDC3A loss disrupts actinotrichia and epidermal organization, implicating the protein in matrix regulation beyond testis adhesion.

   Evidence Hypomorphic CRISPR/Cas9 mutant in zebrafish with gene-expression profiling and fin development/regeneration phenotyping

   PMID:31527654

   Open questions at the time

   • Molecular targets in ECM not identified
   • Connection to ER/secretory function not established
   • Hypomorphic allele leaves null phenotype undefined
6. 2020 High

   Resolved the central molecular function: FNDC3A is an ER membrane protein that anchors the poly(A) polymerase FAM46C/TENT5C to the cytoplasmic ER face, coupling the complex to secretion, lysosome exocytosis, autophagy, and aggregate-driven apoptosis.

   Evidence Reciprocal co-IP, biochemical fractionation, and knockdown/overexpression with aggregate, apoptosis, and autophagy-flux readouts in multiple myeloma cells, replicated in a companion study

   PMID:32963011 PMID:32966780

   Open questions at the time

   • Stoichiometry and structure of the FNDC3A–FAM46C complex unknown
   • Which ER-targeted mRNAs are regulated not comprehensively defined
   • Generality beyond myeloma cells untested
7. 2020 High

   Showed the FNDC3A–FAM46C circuit is regulated by p62, whose ZZ domain sequesters FAM46C and blocks its FNDC3A association and poly(A) polymerase activity, embedding the complex in autophagic/proteostatic control.

   Evidence Co-IP, domain-mapping mutagenesis, confocal imaging of p62 aggregates, and mRNA-stabilization assays across two labs

   PMID:32963011 PMID:32966780

   Open questions at the time

   • Signals controlling p62-mediated sequestration not defined
   • Whether FNDC3A itself is regulated by p62 unknown
8. 2024 Medium

   Identified an extracellular, adipokine-like role: recombinant FNDC3A suppresses IGF1-dependent steroidogenesis and metabolism in granulosa cells and is carried in follicular-fluid extracellular vesicles.

   Evidence In vitro bovine granulosa cell culture with recombinant FNDC3A, hormone/metabolite assays, pAkt western blot, qPCR, and EV isolation

   PMID:38513348

   Open questions at the time

   • Receptor mediating extracellular FNDC3A action unidentified
   • Reconciliation of secreted/EV form with ER-transmembrane topology unclear
   • Single lab, bovine model
9. 2025 Medium

   Placed FNDC3A upstream of the YAP1 oncogenic program by showing its knockdown suppresses EMT, invasion, and stemness in triple-negative breast cancer.

   Evidence siRNA knockdown with invasion/migration and stemness assays plus RNA-seq pathway analysis

   PMID:40120859

   Open questions at the time

   • No rescue experiment
   • Direct FNDC3A–YAP1 interaction not shown
   • Mechanism linking ER anchor function to YAP1 regulation unknown
10. 2026 High

    Defined the binding determinant: a member-specific C-terminal region of TENT5/FAM46 proteins is necessary and sufficient for FNDC3 binding and ER localization, and myeloma mutations there disrupt the interaction and tumor-suppressive output.

    Evidence Systematic mutagenesis with transcriptomic/proteomic profiling, co-IP, and localization assays

    PMID:42247288

    Open questions at the time

    • Reciprocal FNDC3A binding domain not mapped at residue level
    • Structure of the interaction interface unresolved
    • Whether other FNDC3 family members bind distinct TENT5 members untested

• How the ER-anchoring/mRNA-stabilization function mechanistically connects to the organismal roles in cell adhesion, ECM organization, YAP1-driven invasion, and extracellular IGF1 modulation remains unresolved.
• No unifying model linking ER-resident FAM46C anchoring to secreted/adhesive functions
• FNDC3A receptor/effector for its extracellular activities unknown
• Full repertoire of FNDC3A-regulated transcripts and secretory cargo undefined